Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight)
- PMID: 17312986
Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight)
Abstract
Background and aim: Constipation is one of the most common disorders in Western countries and it is known that dietary factors such as a low fiber diet and low caloric intake are associated with this condition. Weight loss can disrupt the intestinal ecosystem resulting in intestinal dysbiosis that worsens constipation. The aim of this study was to evaluate the effects of treatment with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight) on chronic constipation in patients undergoing a weight loss diet.
Methods: Our evaluation included the recording of age, gender, weight, height, BMI, physical activity, constipation, diet, therapy compliance and laxative supplies. A hypocaloric diet (1,200/1,400 cal.) was prescribed to all patients, and they were submitted to a physical activity program and received 1 bag of symbiotic zir fos per day for the entire duration of the study. Patients' follow-up was available for up to 60 days.
Results: Two hundred and ninety seven patients (79.4% women and 18.2% men, mean age 32.2) were included in the study. The mean baseline BMI was 33.4 +/- 5.6 (range 22.8-56.3 Kg). The improvement of constipation turned out to be associated to age (p < 0.01). Patients with a mean age of 35 +/- 12 showed an improvement of constipation. BMI values were not significantly different among the groups of patients with improved, worsened or unchanged constipation. No significative difference was observed among groups due to physical activity. At the follow-up, after 20 days from the beginning of the study, patients that assumed at least 17/20 of the zir fos bags showed a greater improvement of constipation (p < 0.01) than the remaining patients who assumed less than 17/20 of the zir fos bags or that didn't assumed any at all. Patients that assumed laxatives (at least once a week) showedn to be more frequently associated with a worsening of constipation (p < 0.001). Diet compliance does not seem to influence the course of constipation.
Conclusion: Our data demonstrate the utility of symbiotics in improving constipation during hypocaloric diet in the treatment of obesity.
Similar articles
-
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.Minerva Gastroenterol Dietol. 2006 Dec;52(4):349-58. Minerva Gastroenterol Dietol. 2006. PMID: 17108864 Clinical Trial.
-
The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.Nutr J. 2007 Aug 4;6:17. doi: 10.1186/1475-2891-6-17. Nutr J. 2007. PMID: 17683583 Free PMC article.
-
Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation.Hepatogastroenterology. 1998 May-Jun;45(21):727-32. Hepatogastroenterology. 1998. PMID: 9684123 Clinical Trial.
-
Functional constipation.Semin Pediatr Surg. 1995 Feb;4(1):26-34. Semin Pediatr Surg. 1995. PMID: 7728505 Review.
-
Constipation: common-sense care of the older patient.Geriatrics. 1996 Dec;51(12):28-34, 36. Geriatrics. 1996. PMID: 8968286 Review.
Cited by
-
Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.J Microbiol. 2009 Feb;47(1):101-9. doi: 10.1007/s12275-008-0179-y. Epub 2009 Feb 20. J Microbiol. 2009. PMID: 19229497 Clinical Trial.
-
What is the evidence for the use of probiotics in functional disorders?Curr Gastroenterol Rep. 2008 Aug;10(4):379-84. doi: 10.1007/s11894-008-0072-1. Curr Gastroenterol Rep. 2008. PMID: 18627649 Review.
-
The Prevalence and Symptoms Characteristic of Functional Constipation Using Rome III Diagnostic Criteria among Tertiary Education Students.PLoS One. 2016 Dec 20;11(12):e0167243. doi: 10.1371/journal.pone.0167243. eCollection 2016. PLoS One. 2016. PMID: 27997551 Free PMC article. Clinical Trial.
-
Bifidobacterium animalis subsp. lactis TG11 ameliorates loperamide-induced constipation in mice by modulating gut microbiota.Front Microbiol. 2025 Jan 29;16:1525887. doi: 10.3389/fmicb.2025.1525887. eCollection 2025. Front Microbiol. 2025. PMID: 39944653 Free PMC article.
-
Comparison of body mass index on children with functional constipation and healthy controls.J Family Med Prim Care. 2013 Jul;2(3):222-6. doi: 10.4103/2249-4863.120715. J Family Med Prim Care. 2013. PMID: 24479087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical